About: Prevention and Control Strategies for SARS-CoV-2 Infection

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prevention and Control Strategies for SARS-CoV-2 Infection Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Prevention and Control Strategies for SARS-CoV-2 Infection
Creator	Saxena, Shailendra Saxena, S Srivastava, N Srivastava, Nishant
Source	PMC
abstract	The population of 168 countries all over the world is struggling with the outbreak of COVID-19. The outbreak is declared as pandemic and public health emergency of international concern declared by WHO. SARS-CoV-2 responsible for the present health emergency exhibited close resemblance with SARS-CoV. Both the viruses are zoonotic and belong to a large family of viruses Coronaviridae. The complete virus particle is made up of four major structural proteins, namely spikes (S), nucleocapsid (N), membrane (M), and envelope (E) encoded by virus genome. The S protein of virus shows similarity to S protein of SARS-CoV. COVID-19 spreads from person to person, and this makes it more vulnerable for causing infection. Several efforts are taken to find prevention strategies for COVID-19. Researchers across the globe are working to find effective vaccination for SARS-CoV-2. There is no vaccine or medication available till date for COVID-19. Preventive measures such as social distancing, awareness, maintenance of hygiene, isolation, and movement restrictions can help in control of COVID-19 spread. Proper sanitization and cleaned and sanitized public transport can be effective in inhibiting the spread of the virus. In the present situation of medical emergency, cooperation and support by following advices from the WHO and government only facilitate everyone to come over.
has issue date	2020-04-30(xsd:dateTime)
bibo:doi	10.1007/978-981-15-4814-7_11
has license	no-cc
sha1sum (hex)	2186cc8d2832a4501406a4f597ae20f63df4fdac
schema:url	https://doi.org/10.1007/978-981-15-4814-7_11
resource representing a document's title	Prevention and Control Strategies for SARS-CoV-2 Infection
has PubMed Central identifier	PMC7189388
schema:publication	Coronavirus Disease 2019 (COVID-19)
resource representing a document's body	covid:2186cc8d2832a4501406a4f597ae20f63df4fdac#body_text
is schema:about of	named entity 'cooperation' named entity 'pandemic' named entity 'social distancing' named entity 'particle' named entity 'resemblance' named entity 'Infection' named entity 'OUTBREAK' named entity 'GLOBE' named entity 'COOPERATION' named entity 'COVID-19' named entity 'HELP' named entity 'TILL' named entity 'CLOSE' named entity 'VULNERABLE' named entity '168' named entity 'COME' named entity 'DATE' named entity 'S PROTEIN' named entity 'EMERGENCY' named entity 'restrictions' named entity 'complete' named entity 'government' named entity 'SARS-CoV' named entity 'hygiene' named entity 'virus' named entity 'globe' named entity 'emergency' named entity 'health' named entity 'similarity' named entity 'spikes' named entity 'There' named entity 'infection' named entity 'nucleocapsid' named entity 'infection' named entity 'hygiene' named entity 'WHO' named entity 'public health emergency of international concern' named entity 'virus' named entity 'COVID' named entity 'COVID' named entity 'vaccine' named entity 'WHO' named entity 'clinical trial' named entity 'RNA' named entity 'mRNA' named entity 'SARS-CoV-2' named entity 'DNA vaccine' named entity 'recombinant protein' named entity 'protein' named entity 'human population' named entity 'SARS-CoV' named entity 'SARS-CoV' named entity 'COVID' named entity 'vaccine' named entity 'galidesivir' named entity 'protein' named entity 'social distancing' named entity 'symptomatic treatment' named entity 'vaccine' named entity 'COVID-19 pandemic' named entity 'COVID-19' named entity 'SARS' named entity 'Ebola' named entity 'genome' named entity 'Vaccine' named entity 'infection rate' named entity 'COVID-19' named entity 'proofreading mechanism' named entity 'infection' named entity 'gene' named entity 'vaccine' named entity 'vaccines, DNA' named entity 'phase 1' named entity 'subclinical' named entity 'COVID-19' named entity 'nucleocapsid' named entity 'vaccine' named entity 'asymptomatic carriers' named entity 'chloroquine' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software